Medical Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

03:38 ET Capital Health's Specialized Rehabilitation Hospital Selects InterSystems TrakCare to Become a Fully Digital Hospital

166-bed specialty hospital is the UAE's first fully sub-acute, outpatient and long-term rehabilitation facility InterSystems, a global...


03:26 ET Prof. Dr. med. Ralf Eberhardt Presents "Heidelberg Algorithm" for Bronchoscopic Lung Volume Reduction Patient Selection at ERS 2017

At the annual European Respiratory Society (ERS) meeting last week in Milan, Italy, Prof. Dr. med Ralf Eberhardt of Thoraxklinik at Heidelberg...


03:26 ET Presentación del "Algoritmo de Heidelberg" para reducción broncoscópica del volumen pulmonar en la ERS 2017

El Profesor Dr. med Ralf Eberhardt presenta un algoritmo para seleccionar a pacientes para tratamientos de reducción pulmonar En la reunión...


03:26 ET Il prof. Ralf Eberhardt presenta "l'algoritmo di Heidelberg" per la riduzione polmonare broncoscopica dei pazienti selezionati all'ERS 2017

Al meeting annuale della European Respiratory Society (ERS) la scorsa settimana a Milano, il Prof. Dr. Ralf Eberhardt della Thoraxklinik di...


03:26 ET Prof. Dr. med. Ralf Eberhardt stellt Heidelberger Algorithmus zur Selektion von Patienten mit bronchoskopischer Lungenvolumenreduktion bei der ERS 2017 vor

Bei der jährlichen Versammlung der European Respiratory Society (ERS) letzte Woche in Mailand, Italien, stellte Prof. Dr. med Ralf Eberhardt von...


03:05 ET VWR stellt neues Ausrüstungszentrum in der Tschechischen Republik zur weltweiten Unterstützung von Kunden vor

VWR (NASDAQ: VWR), der weltweit führende unabhängige Anbieter von Produkt- und Servicelösungen für Labor- und Produktionskunden, hat die...


03:05 ET VWR annonce un nouveau centre de pré-assemblage en République tchèque afin de soutenir ses clients internationaux

VWR (NASDAQ : VWR) leader mondial indépendant qui fournit des produits et des solutions de service aux clients de laboratoire et de production, a...


03:05 ET VWR anuncia nuevo centro de preparación de lotes en República Checa para brindar soporte a clientes de todo el mundo

VWR (NASDAQ: VWR), el proveedor independiente de soluciones de productos y servicios para laboratorios y clientes de producción líder en el mundo,...


03:00 ET Majority of women do not know early signs of breast cancer, finds global survey by Avon

Only two in five people (42%) are confident about recognising the changes to their breasts that could be a sign of cancer, according to a new...


03:00 ET AMO Pharma Reports Update on Positive Interim Analysis for the First Cohort of Phase IIa Congenital Myotonic Dystrophy Study

AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, debilitating childhood onset neurogenetic disorders...


02:30 ET PharmaMar : Sylentis présente de nouvelles données sur un nouveau pARNi à usage topique pour le traitement des maladies de la rétine évitant les injections intraoculaires

- Ce nouveau traitement expérimental, basé sur l'interférence ARN, atteint la rétine lorsqu'il est administré sous forme de gouttes...


02:15 ET DSM Updates Market on Strategy 2018

Royal DSM, a global science company active in health, nutrition and materials, today updates investors on its progress on Strategy 2018, "Driving...


02:00 ET Norgine lanza un nuevo documento de debate

Norgine lanza un nuevo documento de debate - Scope for Change: ¿ Cuál es el futuro de los servicios europeos de colonoscopia? Norgine B.V....


02:00 ET Norgine lance un nouveau document d'analyse - Opérer des changements: quel avenir pour les services de coloscopie européens?

Norgine B. V. a annoncé aujourd'hui le lancement d'un nouveau document d'analyse intitulé « Scope for change: what next for European colonoscopy...


02:00 ET Norgine veröffentlich neues Diskussionspapier - Koloskopie im Wandel: Ein Ausblick für Europa

Norgine B.V. hat heute die Veröffentlichung eines neuen Diskussionspapiers "Scope for change: what next for European colonoscopy services?"...


Sep 24, 2017, 18:15 ET Immune response prognostic for prostate cancer survival, recurrence and response to radiation therapy

A new study finds that immune response in prostate cancer may be able to forecast how patients will respond to radiation therapy, as well as their...


Sep 24, 2017, 16:15 ET Distress associated with missed appointments and hospital admission during cancer treatment

Psychological distress has long been associated with negative health outcomes for cancer patients, though specific reasons remain unclear. A new...


Sep 24, 2017, 16:15 ET Study at urban cancer center finds 75 percent of its depressed patients were previously undiagnosed

A new study of patients at an urban cancer center points to a potentially serious problem that may limit the impact of clinical cancer...


Sep 24, 2017, 16:00 ET Long-term survival rates more than double previous estimates for locally advanced lung cancer

Long-term results of a phase III clinical trial indicate that survival rates for patients receiving chemoradiation for unresectable, locally...